RVL Pharmaceuticals PLC (FRA:O1P)
€ 0.003 0 (0%) Market Cap: 1.65 Mil Enterprise Value: 38.48 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 0/100

Q4 2021 RVL Pharmaceuticals PLC Earnings Call Transcript

Mar 30, 2022 / 08:30PM GMT
Release Date Price: €1.53 (-4.38%)
Operator

Good day, and thank you for standing by. Welcome to the RVL Pharmaceuticals Fourth Quarter 2021 Earnings Results and Business Update Call. (Operator Instructions)

I would now like to hand the conference over to your speaker today, Lisa Wilson, Investor Relations for RVL. Please go ahead.

Lisa Wilson

Thank you, operator. Welcome to RVL Pharmaceuticals Fourth Quarter 2021 Business Update Call. This is Lisa Wilson, Investor Relations for RVL. With me on today's call are RVL's Chief Executive Officer, Brian Markison; Chief Operating Officer, JD Schaub; and Chief Financial Officer, Andy Einhorn.

This afternoon, the company issued a press release detailing financial results for the 3 months ended December 31, 2021. This press release and a webcast of this call can be accessed through the Investors section of the RVL website at rvl.com.

Before we get started, I would like to remind everyone that any statements made on today's conference call that express a belief, expectation, projection, forecast, anticipation or intent regarding future events

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot